Cystic pancreatic lesions: Current evidence for diagnosis and treatment

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 7-8, 2011, Pages 773-788

  Björk Werner, Josefin ^a   Bartosch Härlid, Anna ^a   Andersson, Roland ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chemotherapy; Diagnosis; IPMN; Mucinous cystadenocarcinoma; Pancreatic cystic neoplasm; Pseudocyst; Serous cystadenoma; Surgery

Indexed keywords

FLUOROURACIL; GEMCITABINE; OXALIPLATIN; PROSTAGLANDIN E2;

ASPIRATION BIOPSY; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CYST FLUID ANALYSIS; CYSTADENOCARCINOMA; CYSTADENOMA; DIAGNOSTIC TEST; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FOLLOW UP; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS CYST; PANCREAS SURGERY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PSEUDOCYST; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PANCREATIC NEOPLASMS; PANCREATIC PSEUDOCYST; WATCHFUL WAITING;

EID: 79960261036     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.551892     Document Type: Review

References (111)

1. DiMagno EP. The pancreatic cyst incidentaloma: management consensus? Clin Gastroenterol Hepatol 2007; 5:797-8.
2. Megibow AJ, Lombardo FP, Guarise A, Carbognin G, Scholes J, Rofsky NM, et al. Cystic pancreatic masses: cross-sectional imaging observations and serial follow-up. Abdom Imaging 2001;26:640-7. (Pubitemid 33130818)
3. Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, et al. Cystic pancreatic neoplasm. Observe or operate? Ann Surg 2004;239:651-9. (Pubitemid 38525636)
4. Brugge WR. Evaluation of pancreatic cystic lesions. Gastrointest Endosc 2004;59:698-707.
5. Zhang J, Wang PJ, Yuan XD. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm. Eur J Radiol 2010;73:96-101.
6. Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y. Analysis of small cystic lesions of the pancreas. Int J Pancreatol 1995;18: 197-206. (Pubitemid 26023501)
7. Warshaw AL, Rutledge PL. Cystic tumors mistaken for pancreatic pseudocysts. Ann Surg 1987;205:393-8. (Pubitemid 17059431)
8. Fernández-del Castillo C, Warshaw AL. Cystic tumors of the pancreas. Surg Clin North Am 1995;75:1001-16.
9. Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999;230:152-61. (Pubitemid 30191880)
10. Loftus Jr EV, Olivares-Pakzad BA, Batts KP, Adkins MC, Stephens DH, Sarr MG, et al. Intraductal papillary mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology 1996; 110:1909-18. (Pubitemid 26169229)
11. Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Widmaier U, Gansauge F, et al. Cystic tumours of the pancreas: diagnostic accuracy, pathologic observations and surgical consequences. Langenbecks Arch Surg 1998;383: 56-61. (Pubitemid 28226340)
12. Sarr MG, Carpenter HA, Prabhakar LP, Ordhard TF, Hughes S, van Heerden JA, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000;231:205-12. (Pubitemid 30078803)
13. Warshaw AL, Compton CC, Lewandrowski K, Cardenosa G, Mueller PR. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 51 patients. Ann Surg 1990;212:432-3.
14. Kitagawa Y, Unger TA, Taylor S, Kozarek RA, Traverso LW. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 2003;7:12-18.
15. Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillary mucinous tumours of the pancreas. Br J Surg 2003; 90:1244-9. (Pubitemid 37330429)
16. Sarr MG, Kendrick ML, Nagorney DM, Thompson GB, Farley DR, Farnell MB. Cystic neoplasms of the pancreas. Benign to malignant epithelial neoplasms. Surg Clin North Am 2001;81:497-509. (Pubitemid 32612112)
17. Hwang DW, Jang JY, Lee SE, Lim CS, Lee KU, Kim SW. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg 2010; Epub ahead of print.
18. Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678-85.
19. de Calan L, Levard H, Hennet H, Fingerhut A. Pancreatic cystadenoma and cystadenocarcinoma: diagnostic value of preoperative morphological investigations. Eur J Surg 1995; 161:35-40.
20. Belsley NA, Pitman MB, Lauwers GY, Brugge WR, Deshphande V. Serous cystadenoma of the pancreas: limitation and pitfalls of endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2008;114:102-10. (Pubitemid 351640789)
21. Colonna J, Plaza JA, Frankel WL, Yearsley M, Bloomston M, Marsh WL. Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients. Pancreatology 2008;8:135-41. (Pubitemid 351670366)
22. Fukukura Y, Fujiyoshi F, Sasaki M, Inoue H, Yonezawa S, Nakajo M. Intraductal papillary mucinous tumors of the pancreas: thin-section helical CT findings. AJR Am J Roentgenol 2000;174:441-7. (Pubitemid 30067154)
23. Sahani DV, Kadavigere R, Saokar A, Fernández-del Castillo C, Brugge W, Hahn P. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005;25:1471-84. (Pubitemid 41695317)
24. Cohen-Scali F, Vilgrain V, Brancatelli G, Hammel P, Vullierme MP, Sauvanet A, et al. Discrimination of unilocular serous cystadenoma from pancreatic pseudocyst and mucinous cystadenoma. Radiology 2003;228:727-33. (Pubitemid 37025483)
25. Fernández-del Castillo C, Warshaw AL. Cystic neoplasm of the pancreas. Pancreatology 2001;1:641-7.
26. D'Onofrio M, Zamboni G, Faccioli N, Capelli P, Pozzi Mucelli R. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 2007;32: 171-81. (Pubitemid 46883656)
27. Sarr MG, Murr M, Smyrk TC, Yeo CJ, Fernandez-del- Castillo C, Hawes RH, et al. Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importancecurrent state-of-the-art and unanswered questions. J Gastrointest Surg 2003;7:417-28. (Pubitemid 36875782)
28. Curry CA, Eng J, Horton KM, Urban B, Siegelman S, Kuszyk BS, et al. CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? Am J Roentgenol 2000;175:99-103. (Pubitemid 30415546)
29. Fugazzola C, Procacci C, Bergamo Andreis IA, Iacono C, Portuese A, Dompieri P, et al. Cystic tumors of the pancreas: evaluation by ultrasonography and computed tomography. Gastrointest Radiol 1991;16:53-61.
30. Minami M, Itai Y, Ohtomo K, Yoshida H, Yoshikawa K, Iio M. Cystic neoplasms of the pancreas: comparison of MR imaging with CR. Radiology 1989;171:53-6. (Pubitemid 19093042)
31. Balci NC, Semelka RC. Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol 2001;2: 113-19. (Pubitemid 32401093)
32. Tanaka M, Chari S, Adsay V, Fernández-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal mucinous neoplasms and mucinous cystic neoplasms of the pancreas. International Association of Pancreatology. Pancreatology 2006;6: 17-32.
33. Scott J, Martin I, Redhead D, Hammond P, Garden OJ. Mucinous cystic neoplasms of the pancreas: imaging features and diagnostic difficulties. Clin Radiol 2000;55:187-92. (Pubitemid 30162574)
34. Visser BC, Yeh BM, Qayyum A, Way LW, McCulloch CE, Coakley FV. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. Am J Roentgenol 2007; 189:648-56. (Pubitemid 47328548)
35. Petrone MC, Arcidiacono PG. Role of endoscopic ultrasound in the diagnosis of cystic tumours of the pancreas. Dig Liver Dis 2008;40:847-53.
36. Rivera JA, Fernández-del Castillo C, Pins M, Compton CC, Lewandrowski KB, Rattner DW, et al. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Ann Surg 1997;225: 637-44; discussion 644-6.
37. Sahani DV, Kadavigere R, Saokar A, Fernández-del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasms of pancreas: multidetector row CT with 2D curved reformations - correlation with MRCP. Radiology 2006;238:560-9. (Pubitemid 43134368)
38. Liu D, Fei L, Björk-Werner J, Andersson R. Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: diagnosis and management. Eur J Gastroenterol Hepatol 2010; in press.
39. Grobmyer SR, Cance WG, Copeland EM, Vogel SB, Hochwald SN. Is there an indication for initial conservative management of pancreatic cystic lesions? J Surg Oncol 2009; 100:372-4.
40. Sperti C, Pasquali C, Guolo P, Polverosi R, Liessi G, Pedrazzoli S. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. Cancer 1996;78:237-43. (Pubitemid 26234565)
41. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 2005;62: 383-9. (Pubitemid 41187940)
42. Centeno BA, Lewandrowski KB, Warshaw AL, Compton CC, Southern JF. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions. Am J Clin Pathol 1994;101:483-7. (Pubitemid 24123242)
43. Weynand B, Deprez P. Endoscopic ultrasound guided fine needle aspiration in biliary and pancreatic diseases: pitfalls and performances. Acta Gastroenterol Belg 2004;67: 294-300. (Pubitemid 39486936)
44. Micames C, Jowell PS, White R, Paulson E, Nelson R, Morse M, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003;58:690-5. (Pubitemid 37370481)
45. Hutchins GR, Draganov PV. Cystic neoplasms of the pancreas: a diagnostic challenge. World J Gastroenterol 2009;15: 48-54.
46. Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003;138:427-3.
47. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330-6. (Pubitemid 38552797)
48. Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, et al. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg 2009;144:345-9.
49. Bassi C, Salvia R, Gumbs AA, Butturini G, Falconi M, Pederzoli P. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3. Langenbecks Arch Surg 2002;387:281-5. (Pubitemid 36061854)
50. Goh BKP, Tan YM, Thng CH, Cheow PC, Chung YFA, Chow PKH, et al. How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesion of the pancreas? Results from a single institution experience with 220 surgically treated patients. J Am Coll Surg 2008;206:17-27. (Pubitemid 350267249)
51. Inan N, Arslan A, Akansei G, Anik Y, Demirci A. Diffusionweighted imaging in the differential diagnosis of cystic lesions of the pancreas. Am J Roentgenol 2008;191:1115-21.
52. Macari M, Finn ME, Bennett GL, Cho KC, Newman E, Hajdu CH, et al. Differentiating pancreatic cystic neoplasms from pancreatic pseudocysts at MR imaging: value of perceived internal debris. Radiology 2009;251:77-84.
53. Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernández-del Castillo C. Serous cystadenoma of the pancreas: tumour growth and recommendations for treatment. Ann Surg 2005;242:413-21. (Pubitemid 41306604)
54. Al-Haddad M, Raimondo M, Woodward T, Krishna M, Pungpapong S, Noh K, et al. Safety and efficacy of cytology brushings versus standard FNA in evaluating cystic lesions of the pancreas: a pilot study. Gastrointest Endoscop 2007;65: 894-8. (Pubitemid 46617520)
55. Kim SY, Lee JM, Kim SH, Shin KS, Kim YJ, An SK, et al. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. Am J Roentgenol 2006;187:1192-8. (Pubitemid 44630821)
56. Recine M, Kaw M, Evans DB, Kririshnamurthy S. Fine-needle aspiration cytology of mucinous tumours of the pancreas. Cancer 2004;102:92-9. (Pubitemid 38489966)
57. Das A, Wells CD, Nguyen CC. Incidental cystic neoplasms of pancreas: What is the optimal interval of imaging surveillance? Am J Gastroenterol 2008;103:1657-62.
58. Taouli B, Vilgrain V, Vullierme MP, Terris B, Denys A, Sauvanet A, et al. Intraductal papillary mucinous tumors of the pancreas: helical CT with histopathologic correlation. Radiology 2000;217:757-64.
59. Brugge WR. Management and outcomes of pancreatic cystic lesions. Dig Liver Dis 2008;40:854-9.
60. Mathieu D, Guigui B, Valette PJ, Dao TH, Bruneton JN, Bruel JM, et al. Pancreatic cystic neoplasms. Radiol Clin North Am 1989;27:163-76. (Pubitemid 19013182)
61. Johnston FR, Myers RT. Etiologic factors and consequences of splenic vein obstruction. Ann Surg 1973;177:736-9.
62. Glynn MJ. Isolated splenic vein thrombosis. Arch Surg 1986; 121:723-5. (Pubitemid 16089943)
63. Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000;24: 1372-7.
64. Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007;133:72-9. (Pubitemid 47031144)
65. Hardacre JM, McGee MF, Stellato TA, Schulak JA. An aggressive surgical approach is warranted in the management of cystic pancreatic neoplasms. Am J Surg 2007;193:374-8.
66. Kawamoto S, Lawler LP, Horton KM, Eng J, Hruban RH, Fishman EK. MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma. Am J Roentgenol 2006;186:687-95. (Pubitemid 46100254)
67. Yamaguchi K, Ogawa Y, Chijiiwa K, Tanaka M. Mucinhypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg 1996;171:427-31. (Pubitemid 26105212)
68. Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds B. Cytological cyst fluid analysis of small (
69. Kubo H, Chijiiwa Y, Akahoshi K, Hamada S, Harada N, Sumii T, et al. Intraductal papillary-mucinous tumors of the pancreas: differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. Am J Gastroenterol 2001;96:1429-34. (Pubitemid 32455070)
70. Schmidt CM, Yip-Schneider MT, Ralstin MC, Wentz S, DeWitt J, Sherman S, et al. PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia. J Gastrointest Surg 2008;12:243-9.
71. Sai JK, Suyama M, Kubokawa Y, Watanabe S, Maehara T. Pancreatic-duct- lavage cytology in candidates for surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas: should the International Consensus Guidelines be revised? Gastrointest Endosc 2009;69:434-40.
72. Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade. Cancer 2006;108:163-73.
73. Brounts LR, Lehmann RK, Causey MW, Sebesta JA, Brown TA. Natural course and outcome of cystic lesions in the pancreas. Am J Surg 2009;197:619-22.
74. Tien YW, Hu RH, Hung JS, Wang HP, Lee PH. Noninvasive pancreatic cystic neoplasms can be safely and effectively treated by limited pancreatectomy. Ann Surg Oncol 2007;15: 193-8.
75. Allen PJ, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006;244:572-82.
76. Lee CJ, Scheiman J, Anderson MA, Hines OJ, Reber HA, Farrell J, et al. Risk of malignancy in resected cystic tumors of the pancreas
77. Gomez D, Rahman SH, Wong LF, Verbeke CS, Menon KV. Predictors of malignant potential of cystic lesions of the pancras. Eur J Surg Oncol 2008;34:876-82.
78. Walsh MR, Vogt DP, Henderson M, Hirose K, Mason T, Bencsath K, et al. Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery 2008;144: 677-85.
79. Fischer WE, Hodges SE, Yagnik V, Morón FE, Wu M, Hilsenbeck SG, et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB 2008;10: 483-90.
80. D'Onofrio M, Gallotti A, Salvia R, Capelli P, Pozzi Mucelli R. Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions. Eur J Radiol 2010; doi:10.1016/j.ejrad.2010.06.015.
81. Mansour JC, Schwartz L, Pandit-Taskar N, D'Angelica M, Fong Y, Larson SM, et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg 2006;10:1354-60. (Pubitemid 44908996)
82. Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. J Gastrointest Surg 2005;9: 22-8.
83. Tann M, Sandrasegaran K, Jennings SH, Skandarajah A, McHenry L, Schmidt CM. Positron-emission tomography and computed tomography of cystic pancreatic masses. Clin Radiol 2007;62:745-51. (Pubitemid 46971644)
84. Khalid A, Zahid M, Finkelstein SD, LeBland JK, Kaushik N, Ahmad N, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009;69:1095-102.
85. Sawhney M, Devarajan S, O'Farrel P, Cury MS, Kunudu R, Vollmer CM, et al. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc 2009;69:1106-10.
86. Wang Y, Gao J, Li Z, Gong Y, Man X. Diagnostic value of mucins (MUC 1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas. Int J Cancer 2007;121:2716-22. (Pubitemid 350136417)
87. Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA, et al. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann Surg 2010;251:937-45.
88. Kokawa A, Kondo H, Gotoda T, Ono H, Saito D, Nakadaira S, et al. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer 2001;91: 333-8. (Pubitemid 32099234)
89. Sahani DV, Saokar A, Hahn P, Brugge WR, Fernandez-del Castillo C. Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? Radiology 2006;238:912-19. (Pubitemid 43289922)
90. Beger HB, Rau BM, Gansauge F, Schwarz M, Siech M, Poch B. Duodenum preserving total pancreatic head resection for cystic neoplasm - a limited but cancer preventive procedure. Arch Surg 2008;393:589-98. (Pubitemid 351643560)
91. Büchler MW, Friess H, Müller MW, Wheatley AM, Beger HG. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 1995;169:65-9; discussion 69-70.
92. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 1998;228:685-91.
93. Yamaguchi K, Yokohata K, Noshiro H, Chijiiwa K, Tanaka M. Mucinous cystic neoplasm of the pancreas or intraductal papillary-mucinous tumour of the pancreas. Eur J Surg 2000;166:141-8. (Pubitemid 30096871)
94. Sugiyama M, Atomi Y, Kuroda A. Two types of mucinproducing cystic tumors of the pancreas: diagnosis and treatment. Surgery 1997;122:617-25. (Pubitemid 27407084)
95. Kanno A, Satoh K, Hirota M, Hamada S, Umino J, Itoh H, et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol 2010;45:952-9.
96. Lee SY, Lee KT, Lee JK, Jeon YH, Choi D, Lim JH, et al. Long-term follow up results of intraductal papillary mucinous tumors of pancreas. J Gastroenterol Hepatol 2005;20: 1379-84. (Pubitemid 43960835)
97. Kim JC, Kim MH, Lee TY, Kim JY, Han JH, Park SJ, et al. Clinicopathologic review of 41 cases of pancreatic mucinous cystic neoplasms. Korean J Gastroenterol 2008;51:60-3.
98. Rafique A, Freeman S, Carroll N. A clinical algorithm for the assessment of pancreatic lesions: utilization of 16- and 64 section multidetector CT and endoscopic ultrasound. Clin Radiol 2007;62:1142-53. (Pubitemid 350018623)
99. Soriano A, Castells A, Ayuso C, Ayuso JR, de Caralt MT, Ginès MA, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004;99:492-501. (Pubitemid 38524129)
100. Manfredi R, Mehrabi S, Motton M, Graziani R, Ferrari M, Salvia R, et al. MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution. Radiol Med 2008;113:414-28. (Pubitemid 351725521)
101. Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123:1500-7. (Pubitemid 35231650)
102. Sahani DV, Lin DJ, Venkatesan AM, Sainani N, Mino- Kenudson M, Brugge WR, et al. Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol 2009;7:259-69.
103. Matsushita M, Ikeura T, Shimatani M, Uschida K, Takoaka M, Nishio A, et al. Pancreatic cystic neoplasms: imaging surveillance for pancreatic and extrapancreatic malignancy. Am J Gastroenterol 2009;104:1055-6.
104. Bradley III EL, Satchidanand SK. Is there a role for chemoradiation in the management of cystadenocarcinoma of the pancreas? Pancreas 2005;31:101-3. (Pubitemid 40911512)
105. Wood D, Silberman AW, Heifetz L, Memsic L, Shabot MM. Cystadenoma of the pancreas: neo-adjuvant therapy and CEA monitoring. J Surg Oncol 1990;43:56-60. (Pubitemid 20039508)
106. Obayashi K, Ohwada S, Sunose Y, Yamamoto K, Igarashi R, Hamada K, et al. Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas. Gan To Kagaku Ryoho 2008;35:1915-17.
107. Turrini O, Waters JA, Schnelldorfer T, Lillemoe KD, Yiannoutsos CT, Farnell MB, et al. Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy. HPB (Oxford) 2010;12:447-55.
108. Barreto G, Shukla PJ, Ramadwar M, Arya S, Shrikhande SV. Cystic tumours of the pancreas. HPB 2007;9:259-66. (Pubitemid 47263959)
109. Irie H, Honda H, Aibe H, Kuroiwa T, Yoshimitsu K, Shinozaki K, et al. MR cholangiopancreatographic differentiation of benign and malignant intraductal mucinproducing tumors of the pancreas. AJR Am J Roentgenol 2000;174:1403-8. (Pubitemid 30261800)
110. Sedlack R, Affi A, Vazquez-Sequeiros E, Norton ID, Clain JE, Wiersema MJ. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc 2002;56: 543-7.
111. Itai Y, Ohhashi K, Nagai H, Murakami Y, Kokubo T, Makita K, et al. 'Ductectatic' mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology 1986;161:697-700. (Pubitemid 17200420)